Mohammed Salhab
Mohammed Salhab, MD, is an oncologist and a hematologist at National Jewish Health. Dr. Salhab is in the Division of Oncology and Department of Medicine.
Director of Community Oncology Practices
Assistant Professor
Northern Hematology-Oncology
Western Hematology-Oncology
Division of Oncology
Department of Medicine
Specialties and ConditionsSpecialties & Conditions
Research AreasResearch Areas

Special Interests

Clinical research for lung cancer, small cell and non small cell lung cancer.

Education

Education
Jordan University,
Residency
Memorial Hospital Of RI/Brown University Internal Medicine,
Fellowship
University of Massachusetts Medical School Hematology and Medical Oncology,

Awards & Recognition

2015: Best senior resident

Board Certification

2015: Internal Medicine
2018: Hematology
2018: Medical Oncology

Professional Memberships

American Society of Clinical Oncology
American Society of Hematology
Society for Immunotherapy of Cancer

Publications

Salhab M, Migdady Y, Donahue M, Xiong Y, Dresser K, Walsh W, Chen BJ, Liebmann J. Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience. J Immunother Cancer. 2018 May 29;6(1):42 16. Zhu X,
 
Salhab M, Donahue M and Walsh W. Pembrolizumab for platinum refractory small cell carcinoma of the prostate, case report. Hematol Med Oncol, 2018
 
Salhab M, Tomaszewicz K, Meng X, Mathew C et all. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in Appendiceal mucinous neoplasms. Human pathology, 2018
 
Epperla, N., Maddocks, K. J., Salhab, M., Chavez, J. C., Reddy, N., Karmali, R., Umyarova, E., Bachanova, V., Costa, C., Glenn, M., Calzada, O., Xavier, A. C., Zhou, Z., Hossain, N. M., Hernandez-Ilizaliturri, F. J., Al-Mansour, Z., Barta, S. K., Chhabra, S., Lansigan, F., Mehta, A., Jaglal, M. V., Evans, A., Flowers, C. R., Cohen, J. B., Fenske, T. S., Hamadani, M. and Costa, L. J. (2017), C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional “hits”and outcomes with subsequent therapy. Cancer.
 
Chemaly RF, Vigil KJ, Saad M, Vilar-Compte D, Cornejo-Juarez P, Perez-Jimenez C, Muba-rak S, Salhab M, Jiang Y, Granwehr B, Adachi JA, Raad I. A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries. Cancer. 2012 Sep; 118 (18): 4627-4633

Ask a Question through Patient Portal

Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account
 

Contact Information

  • Western Hematology Oncology Office: 303.232.0602
  • Northern Hematology Oncology Office: 303.650.4042

 

Locations

  • Western Hematology Oncology
    Red Rocks Medical Center 400 Indiana Street #230
    Golden, CO 80401

  • Northern Hematology Oncology
    9451 Huron St.
    Thornton, CO 80260

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes.

Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.
 
 

Comments

Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.